Episode notes
When an FDA panel held her company’s future in the balance, UroGen Pharma CEO Liz Barrett refused to fold, even with the odds stacked, a plunging stock, and one vote deciding it all.
PODCAST TEAM
Producer and Director: Devon Leaver
Editor: Dominique Guerra
Production Coordinator: YingYu Lin
Production Support: Annabelle Chan
Story Consultants: Partner & Research Analyst Tony Nguyen, and Chief Corporate Finance Officer, Chris Seiter.
Featuring: Liz Barrett, President & CEO of UroGen Pharma, moderated by Stephanie A. Sirota, Partner and Chief Business Officer at RTW Investments, LP.
FOLLOW US
Love our podcast? Follow us on LinkedIn at
Keywords
life scienceshealthcare investingbiotechhealthcanceroncology
Where this episode is made
State